home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Akira

SHARESHARESHARE
Akira is reimagining Canadian healthcare we're changing how healthcare is delivered and empowering patients to be engaged and proactive about their health. Right Health combines virtual and face-to-face care to offer on-demand, accessible healthcare convenience at your fingertips. Akira is the technology platform within Right Health’s offering that provides you with an instant connection to great Canadian doctors, nurse practitioners, and more all by secure text or video through the Akira smartphone app.
SHARESHARESHARE

RELATED NEWS


The US Food and Drug Administration (FDA) has approved Biogen and Alkermes’ oral drug Vumerity (diroximel fumarate) to treat relapsing forms of multiple sclerosis (MS). Biogen holds the exclusive licence to commercialise the drug globally and intends to make it available in the US in the coming days. Biogen chief medical officer and research and development executive vice-president Alfred Sandrock said: “The FDA’s approval of Vumerity delivers on Biogen’s commitment to pu...

READ MORE

Purdue Pharma L.P. today announced the promotion of Maria A. Barton, Esq., Vice President, from Deputy General Counsel to General Counsel. Barton will become a member of the Executive Committee and will report to Purdue Pharma President and Chief Executive Officer Mark Timney, effective immediately....

READ MORE

Black men diagnosed with prostate cancer classified as low risk may actually have a more aggressive form of the disease that is more likely to be fatal than in nonblack men placed in the same prognostic category, a new study suggests. This disparity emerged from research led by a Dana-Farber Cancer Institute scientist and published as a report in JAMA. The study analyzed databases of hundreds of thousands of men diagnosed with prostate cancer and assigned a Gleason score on the basis of a biopsy...

READ MORE

Excited by strong phase II data, Novartis is exercising its option to license Akcea Therapeutics’ TQJ230, a treatment to reduce the risk of cardiovascular disease in people living with elevated levels of inherited lipoprotein(a). TQJ230, previously known as AKCEA-APO(a)-LRx, was discovered by Ionis Pharmaceuticals and has been co-developed to date by Akcea and Ionis. In a deal announced in January 2017, Novartis said it would be working with Ionis to license and develop TQJ230 and another ...

READ MORE

Scientists at North Carolina State University and the University of North Carolina at Chapel Hill have developed a new way of delivering a clot buster and a mitigating drug to limit damage due to reperfusion. Currently, serious blockages leading to the myocardium are typically broken up in the cath lab, usually with a stent left behind to support the vessel. But, it can take significant time between when a patient is admitted and when the clot is physically removed, often resulting in poor outco...

READ MORE

Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progress of the disease, according to new research led by the University of Oxford. Non-sense mediated decay (NMD) is a natural physiological process that provides cells with the ability to detect DNA errors called nonsense mutations....

READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...